[JPM2025] ‘Global pharma showed interest in Mediwhale after we verified AI diagnostic solution Dr. Noon’

SAN FRANCISCO, Calif. — By Kim Chan-hyuk/Korea Biomedical Review correspondent — Mediwhale is accelerating its global expansion, starting with supplying its “Dr. Noon CVD” to Glucare, a diabetes clinic in Dubai, last year.

At the 43rd J.P. Morgan Healthcare Conference (JPM 2025) in San Francisco last Thursday (local time), Mediwhale CEO Choi Tae-geun and COO Nina Shin said that their recent participation in a series of global events confirmed the interest in Dr. Noon CVD and the importance of preventive healthcare.